Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency

NCT04404400 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04404400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04404400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 3
Overall status
Recruiting
Start date
February 17, 2022
Completion date
February 28, 2026
Enrollment
1,092 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness related corticosteroids insufficiency